Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TGF-BETA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | TGF-BETA |
| Key Genes/Proteins | AKT, APOE, APP, BACE1 |
| Related Diseases | Als, ALZHEIMER'S DISEASE, Atherosclerosis, ATHEROSCLEROSIS, CANCER |
graph TD
TGF_BETA["TGF-BETA"]
TGF_BETA -->|"activates"| HEPATOCELLULAR_CARCINOMA["HEPATOCELLULAR CARCINOMA"]
TGF_BETA -->|"activates"| COLORECTAL_CANCER["COLORECTAL CANCER"]
TGF_BETA -->|"activates"| METASTASIS["METASTASIS"]
TGF_BETA -->|"activates"| FIBROSIS["FIBROSIS"]
TGF_BETA -->|"implicated in"| CANCER["CANCER"]
TGF_BETA -->|"activates"| AGING["AGING"]
TGF_BETA -->|"activates"| EGFR["EGFR"]
TGF_BETA -->|"regulates"| FERROPTOSIS["FERROPTOSIS"]
CYTOKINES["CYTOKINES"] -->|"regulates"| TGF_BETA
CANCER -->|"regulates"| TGF_BETA
TNF["TNF"] -->|"activates"| TGF_BETA
IL_6["IL-6"] -->|"regulates"| TGF_BETA
INFLAMMATION["INFLAMMATION"] -->|"activates"| TGF_BETA
VEGF["VEGF"] -->|"activates"| TGF_BETA| Target | Relation | Type | Str |
|---|---|---|---|
| Angiogenesis | correlates_with | process | 0.92 |
| alpha-synuclein induced toxicity | mediates | process | 0.85 |
| PULMONARY HYPERTENSION | involved_in | entity | 0.80 |
| angiogenic properties | correlates_with | process | 0.70 |
| Als | inhibits | disease | 0.65 |
| Atherosclerosis | inhibits | disease | 0.65 |
| APOE | inhibits | gene | 0.60 |
| Tgf-Beta | activates | pathway | 0.60 |
| Macrophage | inhibits | cell_type | 0.60 |
| IL-6 | inhibits | gene | 0.60 |
| CANCER | associated_with | disease | 0.58 |
| HEPATOCELLULAR CARCINOMA | associated_with | disease | 0.44 |
| COLORECTAL CANCER | activates | disease | 0.30 |
| COLORECTAL CANCER | associated_with | disease | 0.30 |
| METASTASIS | activates | process | 0.30 |
| METASTASIS | associated_with | process | 0.30 |
| HEPATOCELLULAR CARCINOMA | activates | disease | 0.30 |
| CANCER | activates | disease | 0.30 |
| AGING | activates | process | 0.30 |
| AGING | regulates | process | 0.30 |
| EGFR | activates | gene | 0.30 |
| FIBROSIS | activates | disease | 0.30 |
| FERROPTOSIS | regulates | process | 0.30 |
| ROS | regulates | protein | 0.30 |
| HEPATOCELLULAR CARCINOMA | inhibits | disease | 0.30 |
| CYTOKINES | regulates | protein | 0.30 |
| STROKE | regulates | disease | 0.30 |
| NF-KB | interacts_with | gene | 0.30 |
| AUTOPHAGY | inhibits | process | 0.30 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CYTOKINES | activates | gene | 0.70 |
| CYTOKINES | regulates | gene | 0.70 |
| CANCER | regulates | gene | 0.70 |
| BMPR1B | participates_in | gene | 0.70 |
| TNF | activates | gene | 0.70 |
| Cancer | regulates | disease | 0.60 |
| Als | protects_against | disease | 0.60 |
| Inflammation | protects_against | disease | 0.60 |
| Longevity | protects_against | disease | 0.60 |
| P53 | contributes_to | gene | 0.60 |
| INFLAMMATION | protects_against | gene | 0.60 |
| P53 | protects_against | gene | 0.60 |
| BMP2 | interacts_with | gene | 0.60 |
| BMP4 | interacts_with | gene | 0.60 |
| APOPTOSIS | treats | gene | 0.60 |
| PARKINSON'S DISEASE | activates | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| IL-6 | activates | gene | 0.60 |
| BCL-2 | treats | gene | 0.60 |
| 6-OHDA | treats | gene | 0.60 |
| Tumor | activates | disease | 0.60 |
| Parkinson | activates | disease | 0.60 |
| Als | treats | disease | 0.60 |
| CYTOKINES | expressed_in | gene | 0.60 |
| TGF-BETA | activates | gene | 0.60 |
| IL-6 | inhibits | gene | 0.60 |
| VEGF | activates | gene | 0.60 |
| LRP1 | activates | gene | 0.60 |
| ABCD3 | regulates | gene | 0.60 |
| MITOCHONDRIA | therapeutic_target | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| BCL-2 | therapeutic_target | gene | 0.60 |
| Hepatocellular Carcinoma | therapeutic_target | disease | 0.60 |
| Als | therapeutic_target | disease | 0.60 |
| Carcinoma | therapeutic_target | disease | 0.60 |
| Hepatitis | therapeutic_target | disease | 0.60 |
| Autoimmune | therapeutic_target | disease | 0.60 |
| Cirrhosis | activates | disease | 0.60 |
| Hypertension | activates | disease | 0.60 |
| Fibrosis | activates | disease | 0.60 |
| AND | associated_with | gene | 0.60 |
| TNF | regulates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| IL-6 | regulates | gene | 0.60 |
| APOE | inhibits | gene | 0.60 |
| NGF | treats | gene | 0.60 |
| FAS | treats | gene | 0.60 |
| EGF | activates | gene | 0.60 |
| Als | inhibits | disease | 0.55 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| BBB leak induces secondary pericyte senescence through TGF-b | 0.560 | neurodegeneration | Does pericyte senescence drive BBB break |
| Early Postnatal TGF-beta Signaling Establishes Lifelong Regi | 0.500 | neuroinflammation | How do regional, age, and sex-dependent |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning TGF-BETA in their description or question text
No additional research found